US › Healthcare

Benitec Biopharma Ltd ADR (BNTC)

US · Healthcare · Biotechnology

$12.52+3.05%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$0
Net profit
$-11.9M
Profit YoY
+17.7%
EPS
$-0.24
EPS estimate
$-0.28

EPS came in at -0.24 against a street estimate of -0.28 — a beat of 14.3%.

Key statistics

Market cap
$417.4M
Forward P/E
0.0
P/B
2.20
Book value
$5.34
EPS (TTM)
$-0.93
52-week high
$16.76
52-week low
$9.85
50-day MA
$11.97
200-day MA
$12.37
Beta
0.26

Analyst view

Analysts rate Benitec Biopharma Ltd ADR a strong buy (7 buy, 0 hold, 0 sell out of 7) with an average price target of $24.17.

Shareholding

Insiders
2.55%
Institutions
98.58%

Largest institutional holders

FundStake
Suvretta Capital Management, LLC33.62%
HHG PLC8.37%
Franklin Resources Inc6.92%
Adage Capital Partners Gp LLC6.17%
RA Capital Management, LLC5.39%
Nantahala Capital Management, LLC4.19%
BlackRock Inc3.45%
Vanguard Group Inc3.42%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Benitec Biopharma Ltd ADR — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.